L. M. Resende

L. M. Resende

Auto-generated profile, based on publicly available information

L. M. Resende

Biochemistry Department, State University of Campinas, 13083-970 Campinas, SP, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BCBruna Mara Aparecida De Carvalho
Bruna Mara Aparecida De Carvalho
JSJ. D. L. Santos
J. D. L. Santos
BXB. M. Xavier
B. M. Xavier
José Rafael de AlmeidaJosé Rafael de Almeida
José Rafael de Almeida
LRL. M. Resende
L. M. Resende
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
Ophidian envenomation is an important health problem in Brazil and other South American countries. In folk medicine, especially in developing countries, several vegetal species are employed for the treatment of snakebites in communities that lack prompt access to serum therapy. However, the identification and characterization of the effects of several new plants or their isolated compounds, which are able to inhibit the activities of snake venom, are extremely important and such studies are imperative. Snake venom contains several organic and inorganic compounds; phospholipases A2(PLA2s) are one of the principal toxic components of venom. PLA2s display a wide variety of pharmacological activities, such as neurotoxicity, myotoxicity, cardiotoxicity, anticoagulant, hemorrhagic, and edema-inducing effects. PLA2inhibition is of pharmacological and therapeutic interests as these enzymes are involved in several inflammatory diseases. This review describes the results of several studies of plant extracts and their isolated active principles, when used against crude snake venoms or their toxic fractions. Isolated inhibitors, such as steroids, terpenoids, and phenolic compounds, are able to inhibit PLA2s from different snake venoms. The design of specific inhibitors of PLA2s might help in the development of new pharmaceutical drugs, more specific antivenom, or even as alternative approaches for treating snakebites.